Although Mg 2ϩ contributes to blood pressure regulation partly in terms of vasodilator action, its sympatholytic effect may also play an important role to control blood pressure. Thus, in the present study, we investigated the effect of Mg 2ϩ on sympathetic tone and blood pressure. We studied its actions on the blood pressure response to hydralazine, a direct vasodilator, in conscious spontaneously hypertensive rats (SHRs), and to electrical stimulation in the pithed Sprague-Dawley rat; catecholamine release by peripheral sympathetic nerve endings; and the N-type Ca 2ϩ channels of cultured neural cells. Intravenous Mg 2ϩ infusion (MgSO 4 : 3ϫ10 Ϫ6 mol/kg body weight/min) induced the greater hypotensive response to hydralazine with attenuated reflex tachycardia in SHRs. In pithed rats, Mg 2ϩ infusion significantly attenuated the blood pressure elevation (2Ϯ2 mm Hg versus 27Ϯ6 mm Hg, PϽ0.01) in response to spinal electrical stimulation. In the perfused mesenteric arteries system, norepinephrine release was significantly attenuated (51Ϯ2%, PϽ0.01) by high Mg 2ϩ concentration solution (4.8 mmol/L) compared with normal Mg 2ϩ solution (1.2 mmol/L). When we applied the perforated whole-cell patch clamp method to nerve growth factor-treated PC12 cells, Mg 2ϩ blocked voltage-gated Ca 2ϩ currents in a concentration-dependent manner. The majority of the voltage-gated Ca 2ϩ currents were carried through N-type channels, followed by L-type channels. Mg 2ϩ blocked both of these channels. These findings suggest that Mg 2ϩ blocks mainly N-type Ca 2ϩ channels at nerve endings, and thus inhibits norepinephrine release, which decreases blood pressure independent of its direct vasodilating action. (Hypertension. 2004;44:897-902.) 
T he second most plentiful cation in intracellular fluid and an essential element for the activity of many enzymes is Mg 2ϩ . 1 In addition to these biochemical actions, magnesium salts have been shown to lower blood pressure. 2, 3 The hypotensive effect of Mg 2ϩ has been found to be mediated by nonspecific antagonism of the Ca 2ϩ channels in vascular smooth muscle cells. 4, 5 On the contrary, Mg 2ϩ deficiency results in a high catecholamine level, altered barofunction, and hypertension. 6, 7 Sympathoactivation and catecholamine elevation induce tachycardia, glucose intolerance, and abnormal fat metabolism, as well as direct cardiotoxicity. 8, 9 At the same time, recent clinical studies revealed that Mg 2ϩ protects brain from ischemic damages. 10, 11 The mechanism for neuroprotection of Mg 2ϩ is not fully elucidated; however, similar to Mg 2ϩ effect on vasculature, it is speculated that Mg 2ϩinduced decrease in intracellular Ca 2ϩ plays an important role. It can be hypothesized that Mg 2ϩ effect on Ca 2ϩ homeostasis in neural cells may be a common mechanism between sympathoinhibitory and neuroprotective action of Mg 2ϩ .
In the present study, we performed in vivo and ex vivo experiments to investigate the effect of Mg 2ϩ on circulatory control by modulating sympathetic tone. Also, we investi-gated the in vitro effect of extracellular Mg 2ϩ concentrations on the voltage-gated Ca 2ϩ current of nerve growth factor (NGF)-differentiated PC12 cells, which have characteristics in common to peripheral sympathetic nerves. 12, 13 Methods For a detailed Methods section, please see http://hyper.hypertensionaha.org.
All protocols in this study were approved by the ethics committee of our institution, and rats were handled in our accredited facility in accordance with the institutional animal care policies of the University of Tokyo. All research protocols conformed to the guiding principles for animal experimentation as enunciated by the Ethics Committee on Animal Research of the University of Tokyo, Faculty of Medicine.
Protocol 1: Sympatholytic Effect of Mg 2؉ and Blood Pressure Changes In Vivo
Male spontaneously hypertensive rats were used in this experiment. The rats were divided into 2 groups: Mg 2ϩ group (nϭ8) and a control group (nϭ7). In the Mg 2ϩ group, MgSO 4 (3ϫ10 Ϫ6 mol/kg body weight/min) was infused, and in the control group saline was infused. Responses to hydralazine (1, 3, and 6ϫ10 Ϫ5 g/kg body weight) were observed. A 100 L blood sample was drawn before and after saline or MgSO 4 infusion to measure the serum Mg level. The nadir mean arterial pressure (MAP) and peak heart rate (HR) in 2 groups were compared.
Male Sprague-Dawley rats were pithed as described elsewhere. 14 Briefly, rats were pithed by inserting a steel rod covered with enamel except at its tip (5 mm), and its end was positioned at the level of the 7th to 10th thoracic vertebrae. The rats were divided into 2 groups as described. After infusion for 20 minutes, we stimulated at 0.5 Hz for 1 minute with an electrical stimulator between the pithing rod and the indifferent electrode. Each stimulus was 50 V and 1 millisecond. Blood pressure and HR changes were observed. To confirm quality of pithing, the rats were injected with 1 mg/kg hexamethonium, and responses to electrical stimulation were observed after the aforementioned experiments.
Protocol 2: Effect of Mg 2؉ on Norepinephrine Release by Peripheral Sympathetic Nerve Ending
The superior mesenteric artery from Sprague-Dawley rats was prepared by a modification of Castellucci method. 15 The preparations were perfused with a Krebs-Henselit solution with 1.2 mmol/L of Mg 2ϩ . Low-Mg 2ϩ buffer was prepared by reducing the MgSO 4 concentration to 0.3 mmol/L substitution with Na 2 SO 4 , and high-Mg 2ϩ buffer with a magnesium concentration of 3.6 mmol/L was prepared by replacing NaCl with MgCl 2 iso-osmotically.
A platinum electrode was placed around the periarterial plexus of the mesenteric artery, and every 15 minutes we stimulated at 8 Hz for 1 minute. Each stimulus was 10 V and 1 millisecond. The perfusate through the mesenteric vascular preparation was collected for measurement of norepinephrine (NE) by high-performance liquid chromatography. 15 NE overflow was defined as NE content of perfusates per wet mesenteric artery weight. To identify component of NE overflow that was affected by Mg 2ϩ , we applied cocaine, a specific blocker of NE reuptake by nerve tissue, 16 or deoxycorticosterone, a blocker of NE uptake by non-neuronal tissue. 17
Protocol 3: Effect of Extracellular Mg 2؉ on Voltage-Gated Ca 2؉ Channels
The PC12 cells were cultured in Dulbecco modified eagle medium containing 10% fetal calf serum and 2.5 S NGF (10 ng/mL) for 7 days. We selected cells with neurite outgrowth for the electrophysiology experiments.
The perforated whole-cell clamp technique 18 was used to avoid the run-down of voltage-gated Ca 2ϩ currents. Ba 2ϩ ion was used as a charge carrier through the voltage-gated Ca 2ϩ channels. The standard patch electrode solution contained 1.2 mmol/L of Mg 2ϩ . Low-Mg 2ϩ and the high-Mg 2ϩ extracellular solutions were prepared as described in protocol 2. Extracellular solutions containing different concentrations of Mg 2ϩ were applied by changing the perfusion solution. All the data were corrected for the liquid junction potential (Ϫ4 to Ϫ2 mV). Amphotericin B (200 g/mL) was used for the perforated whole-cell clamp experiments.
An L-type Ca 2ϩ channel blocker, nitrendipine (NIT) (5 mol/L), and an N-type Ca 2ϩ channel blocker, -conotoxin GVIA (-CgTX) (1 mol/L), were used to identify the type of voltage-gated Ca 2ϩ current.
Statistical Analysis
In protocol 2, the average of the control responses of NE overflow to electrical stimulation and the following 2 responses in the different Mg 2ϩ concentration buffers or in the presence of drugs were calculated. The results are expressed as total NE overflow standardized by tissue weight and the percent change from the averaged NE overflow in control buffer.
Data are shown as meansϮSEM in protocols 1 and 2 and as meansϮSD in protocol 3. The statistical analysis in protocol 2 was performed by the paired and unpaired Student t test, and in protocols 1 and 3 by analysis of variance (ANOVA). PϽ0.05 was considered indicative of statistical significance.
Results

Protocol 1: Sympatholytic Effect of Mg 2؉ and Blood Pressure Changes In Vivo
The body weight of the rats infused with Mg 2ϩ (Mg 2ϩ group) was 241Ϯ2g, their baseline MAP was 175Ϯ5 mm Hg, and their HR was 453Ϯ9 bpm, which were not affected by the Mg 2ϩ infusion (MAP, 170Ϯ4 mm Hg; HR, 440Ϯ7 bpm). The serum Mg level significantly increased from 2.5Ϯ0.05 mg/dL to 3.5Ϯ0.11 mg/dL after Mg 2ϩ infusion (PϽ0.01). The body weight of the rats in the control group was 245Ϯ4g, their baseline MAP was 173Ϯ3 mm Hg, and their HR was 442Ϯ12 bpm. None of those parameters changed much after saline infusion in the control group (MAP, 174Ϯ5 mm Hg; HR, 444Ϯ10 bpm; serum magnesium from 2.5Ϯ0.05 mg/dL to 2.5Ϯ0.06 mg/dL). Hydralazine decreased MAP dosedependently and the decrease was more prominent in the Mg 2ϩ group than control group (Figure 1a) , whereas HR increased more in the control group than in the Mg 2ϩ group (Figure 1b ).
Blood Pressure Response to Electrical Stimulation in Pithed Sprague-Dawley Rats
The body weight of the rats infused with Mg 2ϩ (Mg 2ϩ group) was 271Ϯ10g, their baseline MAP after pithing was 55Ϯ11 mm Hg, and their HR was 206Ϯ25 bpm. The body weight of the rats in the control group was 275Ϯ16g, their baseline MAP after pithing was 53Ϯ10 mm Hg, and their HR was 208Ϯ22 bpm. Electrical stimulation significantly increased both MAP and HR, but the extent of the increase was greater in the control group than in the Mg 2ϩ group (Figure 2 ). The pressor responses to electrical stimulation were completely abolished (nϭ3; MAP, 55Ϯ8 to 53Ϯ4 mm Hg; HR, 205Ϯ10 to 204Ϯ8 bpm) by 1 mg/kg hexamethonium, suggesting that the pressor response reflects peripheral sympathetic stimulation.
Protocol 2: Effect of Mg 2؉ on NE Release From Peripheral Sympathetic Nerve Endings
NE overflow at 1.2 mmol/L Mg 2ϩ was 0.266Ϯ0.032 ng/g tissue weight, and percent change of NE overflow with each buffer is shown in the Table. High-Mg 2ϩ buffer significantly suppressed NE overflow.
In the presence of cocaine or deoxycorticosterone, the high-Mg 2ϩ buffer significantly attenuated NE overflow, and the Mg 2ϩ -induced changes were not significantly altered.
Protocol 3: Effect of Extracellular Mg 2؉ on the Voltage-Gated Ca 2؉ Currents
To determine the effect of extracellular Mg 2ϩ on NE release, we investigated the effect of extracellular Mg 2ϩ on the voltage-gated Ca 2ϩ currents of PC12 cells differentiated by NGF. Figure 3A shows the Ba 2ϩ currents through voltagegated Ca 2ϩ channels recorded under the voltage clamp from a PC12 cell at 3 different extracellular Mg 2ϩ concentrations. The holding potential was Ϫ74 mV, and a test pulse step to 6 mV was applied. The Ba 2ϩ current exhibited a clear inactivation process, but the steady current persisted. The Ba 2ϩ current first appeared at a potential step to Ϫ34 mV. As the depolarizing steps became greater, the amplitude of the Ba 2ϩ current increased. When the extracellular Mg 2ϩ concentration was changed sequentially, the amplitude of the peak current was largest in the 0. The current-potential relationships of the Ba 2ϩ current in the extracellular solutions containing 3 different Mg 2ϩ concentrations are shown in Figure 3B . Increased extracellular Mg 2ϩ induced a decrease in amplitude of the Ba 2ϩ current at all potentials, indicating that inhibition of the Ba 2ϩ current was not voltage-dependent. Figure 3C summarizes the amplitude of the Ba 2ϩ current at the 3 Mg 2ϩ concentrations. The amplitude of the peak Ba 2ϩ current in the standard extracellular solution was normalized as 100% in each record. Extracellular Mg 2ϩ inhibited the Ba 2ϩ current in a concentration-dependent manner when analyzed by repeated measures ANOVA with post-test for linear trend. We could observe significant linear trend (PϽ0.0001). Figure 4A shows the sequential effect of NIT (5 mol/L) and 4.8 mmol/L Mg 2ϩ on the Ba 2ϩ current. Application of NIT decreased the current by Ϸ17% of the control, and additional application of high-Mg 2ϩ solution inhibited the current by an additional 21% of the control. Figure 4B shows the sequential effect of -CgTX (1 mol/L) and 4.8 mmol/L Mg 2ϩ on the Ba 2ϩ current, and application of -CgTX decreased the current by Ϸ78% of the control. Additional application of 4.8 mmol/L Mg 2ϩ solution inhibited the current by only an additional 5% of the control. Figure 4C summarizes the data obtained in these experiments. Application of NIT inhibited the Ba 2ϩ current to 83.5Ϯ5.6% (nϭ15) of the control, and additional application of 4.8 mmol/L Mg 2ϩ inhibited it to 59.4Ϯ7.5% (nϭ15) of the control. There was a significant difference (PϽ0.001 by paired t test) between the current after NIT and after NIT plus 4.8 mmol/L Mg 2ϩ . Application of -CgTX inhibited the Ba 2ϩ current to 13.1Ϯ2.6% (nϭ15) of the control, and additional application of 4.8 mmol/L Mg 2ϩ inhibited it to 7.7Ϯ1.3% (nϭ15) of the control. There was a significant difference (PϽ0.001 by paired t test) between the current after -CgTX and after -CgTX plus 4.8 mmol/L Mg 2ϩ . The current-potential relationships of the non-L-type currents and non-N-type currents before and after high Mg 2ϩ (4.8 mmol/L) application are shown in Figure 5A and B, respectively. Both non-L-type and non-N-type currents were inhibited by high Mg 2ϩ . These results indicated that the Ba 2ϩ current in NGF-treated PC12 cells was mainly carried through N-type Ca 2ϩ channels and the majority of the remaining current was L-type Ca 2ϩ channels, and that both of these currents are inhibited by high Mg 2ϩ .
Percent Change of Norepinephrine Overflow From Peripheral Nerve Endings
Discussion
Mg 2ϩ is reported to modulate cardiac function and vasomotor control by nonspecific antagonism of the Ca 2ϩ channels. 4,5,7,19 -21 Mg 2ϩ also modulates neuronal activity 6, 7 but the precise mechanisms are still unknown. In the present study, we showed an Mg 2ϩ effect on sympathetic tone both in in vivo and in vitro studies. Firstly, using both conscious spontaneously hypertensive rats and pithed rats, we showed that Mg 2ϩ possesses sympatholytic effects and reduces blood pressure. Secondary, using perfused mesenteric artery preparation, we revealed that Mg 2ϩ reduces norepinephrine release. Finally, Mg 2ϩ inhibits N-type Ca 2ϩ channels in differentiated PC12 cells. The results of the present study indicate that Mg 2ϩ attenuated sympathetic tone mainly by inhibiting N-type Ca 2ϩ channels.
Mg 2ϩ augmented the antihypertensive effect of hydralazine and attenuated the reflex tachycardia. It suggests that Mg 2ϩ exerts an inhibitory effect on sympathetic tone and enhances the vasodilator effect of hydralazine. To further investigate roles of peripheral sympathetic nerves on blood pressure regulation, we applied the mechanically pithed preparation in which central nervous activities are fully destroyed and also we can avoid pharmacological interference. Electrical stimuli were applied at the level of 7th to 10th thoracic vertebrae to direct stimulation of cardiac sympathetic nerve be possible. 14 Mg 2ϩ attenuated blood pressure elevation evoked by sympathetic nerve stimulation. Norepinephrine is a main factor that is released by electrical stimulation and regulates blood pressure in the pithed model; however, other circulatory factors could be released. Thus, we applied ex vivo model to investigate effect of Mg 2ϩ on norepinephrine release. We measured NE overflow from the periarterial plexus of the mesenteric artery. There are 2 components to NE overflow: NE release from nerve endings and NE reuptake into nerve terminals and other tissue. We showed that Mg 2ϩ affects NE release but not uptake by using uptake blockers such as cocaine 16 and deoxycorticosterone. 17 To specify Mg 2ϩ effect on Ca 2ϩ channels that play a pivotal role in sympathetic activity, we used NGF-treated PC12 cells. NGF-treated PC12 cells exhibited neurite outgrowth. Ap-proximately 90% of the voltage-gated Ca 2ϩ channel currents were composed of -CgTX-sensitive N-type Ca 2ϩ currents. An L-type Ca 2ϩ channel blocker, NIT, reduced Ca 2ϩ influx to a smaller extent than -CgTX. These characteristics are consistent with those of differentiated PC12 cells, which have characteristics similar to those of noradrenergic sympathetic neurons, including the development of N-type Ca 2ϩ channels. 12, 13, 22 In the present study, Mg 2ϩ further inhibited the Ba 2ϩ current after treatment with NIT but not after -CgTX, suggesting that Mg 2ϩ inhibits N-type Ca 2ϩ channels. The high Mg 2ϩ -induced inhibition of N-type Ca 2ϩ channels observed in the present study was similar to the effect of proadrenomedullin N-terminal 20 peptide on the N-type current in NGF-treated PC 12 cells. 18 This inhibition of the N-type Ca 2ϩ current plays a role in the inhibition of Ca 2ϩ influx through voltage-gated Ca 2ϩ channels and as a result reduces the intracellular Ca 2ϩ concentration.
Based on these results, extracellular Mg 2ϩ blocks N-type and partly L-type Ca 2ϩ channels, and thus inhibits NE release, and these effects play an important role in regulating sympathetic tone and blood pressure.
Perspectives
Recent large clinical studies have shown that the lower the blood pressure obtained by treatment, the more successful in preventing hypertensive patients from cardiovascular events. [23] [24] [25] Although dihydropyridine Ca 2ϩ channel blockers are potent antihypertensive agents, short-acting Ca 2ϩ channel blockers have been shown to be unfavorable for the treatment of hypertension. 26 This may be partly caused by reflex sympathoactivation and catecholamine release, which induce unfavorable effects. 8, 9 Several epidemiological studies have supported tachycardia, an indicator of sympathetic tone, as an independent risk factor for cardiovascular death in elderly men. 27 Because all vasodilators induce reflex sympathoactivation in hypertensive patients, treatment that aims to reduce sympathoactivation can achieve a greater therapeutic effect. Because Mg 2ϩ decreases NE release from nerve endings by inhibiting voltage-gated N-type Ca 2ϩ currents, Mg 2ϩ may be beneficial in preventing organ damage by inhibiting reflex sympathoactivation. In fact, some studies have shown that Mg 2ϩ supplementation improves the outcome of cardiovascular diseases. 11, 28 However, the antihypertensive action of Mg 2ϩ is very weak. 29 It led us to the speculation that Ca 2ϩ 
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